#rlay
Latest news and interesting information about rlay.
Citizens Raises Relay Price Target to $21
Citizens raises Relay Therapeutics price target to $21 on strong trial data for zovegalisib, with shares up 296%.
Relay Therapeutics Launches $175M Stock Offering
Relay Therapeutics launches $175 million stock offering. See details on the offering, zovegalisib progress, and analyst ratings. Bond.az covers the latest.
Relay Therapeutics Stock Upgrade Boosts Price
Relay Therapeutics stock upgraded by Jones Trading to Buy with $20 target after positive zovegalisib trial data.
Relay Therapeutics stock surges 15%
Relay Therapeutics stock surges 15% after positive data from Phase 2 trial for zovegalisib in vascular anomalies.
...